20 May 2013
Keywords: vectura, licenses, copd, drugs, sandoz, uk-based, pulmonary
Article | 15 September 2008
UK-based pulmonary drug developer Vectura has licensed to Sandoz, the generics division of Swiss drug major Novartis, the exclusive rights ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 September 2008
17 May 2013
© 2013 thepharmaletter.com